Insulet - 18 Year Stock Price History | PODD

Historical daily share price chart and data for Insulet since 2007 adjusted for splits and dividends. The latest closing stock price for Insulet as of August 19, 2025 is 327.48.
  • The all-time high Insulet stock closing price was 330.23 on May 12, 2023.
  • The Insulet 52-week high stock price is 329.33, which is 0.6% above the current share price.
  • The Insulet 52-week low stock price is 180.31, which is 44.9% below the current share price.
  • The average Insulet stock price for the last 52 weeks is 268.41.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Insulet Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 283.4836 256.8500 327.4800 237.0600 327.4800 25.44%
2024 206.3048 209.1100 275.7000 161.0200 261.0700 20.32%
2023 248.4888 286.3800 330.2300 127.7700 216.9800 -26.30%
2022 249.8594 275.7000 313.0000 186.4000 294.3900 10.64%
2021 278.8988 251.6200 318.2900 225.5200 266.0700 4.08%
2020 208.4215 169.7700 265.8900 130.0100 255.6300 49.32%
2019 124.3880 73.4300 186.0000 72.4400 171.2000 115.83%
2018 86.4903 69.0000 108.1300 68.4900 79.3200 14.96%
2017 51.6703 37.3500 71.8000 36.9800 69.0000 83.12%
2016 34.8554 37.0600 45.0700 24.6800 37.6800 -0.34%
2015 31.7918 45.1800 45.1800 25.6400 37.8100 -17.91%
2014 40.4507 35.8300 50.1800 31.6900 46.0600 24.15%
2013 30.5954 21.4900 39.8600 21.0200 37.1000 74.84%
2012 20.0656 19.0600 22.1500 16.9300 21.2200 12.69%
2011 18.4227 16.0700 23.0400 14.2900 18.8300 21.48%
2010 14.7499 15.0300 16.4700 12.7500 15.5000 8.54%
2009 8.3167 7.8400 14.4000 2.6700 14.2800 84.97%
2008 14.3112 23.4200 25.8700 3.2100 7.7200 -67.12%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $23.052B $2.072B
Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $228.435B 26.79
Boston Scientific (BSX) United States $153.732B 36.66
Stryker (SYK) United States $149.077B 30.35
EssilorLuxottica (ESLOY) France $146.011B 0.00
Medtronic (MDT) Ireland $115.234B 16.26
Lonza Group Ag (LZAGY) Switzerland $48.493B 0.00
Haleon (HLN) United Kingdom $43.717B 24.97
ResMed (RMD) United States $41.881B 29.95
Agilent Technologies (A) United States $34.119B 22.24
GE HealthCare Technologies (GEHC) United States $33.772B 15.87
Terumo (TRUMY) Japan $27.820B 32.97
Koninklijke Philips (PHG) Netherlands $26.548B 17.56
Zimmer Biomet Holdings (ZBH) United States $20.663B 13.15
Smith & Nephew SNATS (SNN) United Kingdom $16.153B 0.00
Baxter (BAX) United States $12.496B 9.65
Sunny Optical Technology (SNPTF) China $10.800B 0.00
Demant (WILYY) Denmark $8.121B 0.00
Bio-Rad Laboratories (BIO) United States $7.804B 28.67
Lantheus Holdings (LNTH) United States $3.750B 10.14
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.442B 24.08
Perrigo (PRGO) Ireland $3.247B 8.11
Prestige Consumer Healthcare (PBH) United States $3.219B 14.28
ICU Medical (ICUI) United States $3.055B 20.80
Haemonetics (HAE) United States $2.616B 11.68
LeMaitre Vascular (LMAT) United States $2.158B 46.28
QuidelOrtho (QDEL) United States $1.816B 11.43
AtriCure (ATRC) United States $1.781B 0.00
Curaleaf Holdings (CURLF) Canada $1.676B 0.00
Green Thumb Industries (GTBIF) United States $1.566B 67.25
Phibro Animal Health (PAHC) United States $1.291B 16.50
AdaptHealth (AHCO) United States $1.279B 18.17
Neogen (NEOG) United States $1.219B 19.34
Acuren (TIC) United States $1.209B 0.00
BioLife Solutions (BLFS) United States $1.176B 2454.00
Tilray Brands (TLRY) Canada $1.167B 0.00
Valneva SE (VALN) France $0.975B 0.00
InMode (INMD) Israel $0.896B 8.29
Kestra Medical Technologies (KMTS) United States $0.805B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.639B 0.00
SNDL (SNDL) Canada $0.552B 0.00
ZimVie (ZIMV) United States $0.534B 20.60
Surmodics (SRDX) United States $0.534B 0.00
Verano Holdings (VRNOF) United States $0.506B 0.00
Cresco Labs (CRLBF) United States $0.501B 0.00
VAREX IMAGING (VREX) United States $0.468B 16.10
Evolus (EOLS) United States $0.461B 0.00
CeriBell (CBLL) United States $0.432B 0.00
Owens & Minor (OMI) United States $0.414B 3.67
Capricor Therapeutics (CAPR) United States $0.351B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
Sanuwave Health (SNWV) United States $0.315B 0.00
Canopy Growth (CGC) Canada $0.300B 0.00
Omeros (OMER) United States $0.297B 0.00
Sanara MedTech (SMTI) United States $0.275B 0.00
Brainsway (BWAY) Israel $0.273B 55.65
Viemed Healthcare (VMD) United States $0.270B 20.44
Aurora Cannabis (ACB) Canada $0.269B 0.00
TerrAscend (TSNDF) Canada $0.262B 0.00
High Tide (HITI) Canada $0.248B 0.00
Quanterix (QTRX) United States $0.234B 0.00
Cerus (CERS) United States $0.228B 0.00
Vireo Growth (VREOF) United States $0.217B 0.00
Exagen (XGN) United States $0.212B 0.00
OraSure Technologies (OSUR) United States $0.205B 0.00
Organigram Global (OGI) Canada $0.204B 0.00
Utah Medical Products (UTMD) United States $0.187B 15.61
TriSalus Life Sciences (TLSI) United States $0.176B 0.00
FitLife Brands (FTLF) United States $0.157B 19.38
Biote (BTMD) United States $0.149B 4.95
Jushi Holdings (JUSHF) United States $0.103B 0.00
Jin Medical (ZJYL) China $0.095B 0.00
Quipt Home Medical (QIPT) United States $0.094B 0.00
MacroGenics (MGNX) United States $0.094B 0.00
Fonar (FONR) United States $0.094B 12.09
Oramed Pharmaceuticals (ORMP) United States $0.084B 0.00
Apyx Medical (APYX) United States $0.075B 0.00
Safety Shot (SHOT) United States $0.071B 0.00
Cytosorbents (CTSO) United States $0.068B 0.00
Agape ATP (ATPC) $0.064B 0.00
ImmuCell (ICCC) United States $0.053B 31.05
Veru (VERU) United States $0.047B 0.00
Zynex (ZYXI) United States $0.047B 0.00
Nephros (NEPH) United States $0.044B 34.42
Modular Medical (MODD) United States $0.039B 0.00
Rockwell Medical (RMTI) United States $0.036B 0.00
United-Guardian (UG) United States $0.036B 13.98
Trinity Biotech (TRIB) Ireland $0.025B 0.00
Senestech (SNES) United States $0.023B 0.00
INLIF (INLF) $0.017B 0.00
Allurion Technologies (ALUR) United States $0.017B 0.00
IM Cannabis (IMCC) Canada $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Flora Growth (FLGC) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.008B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00